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Abstract
Estradiol participates in the control of energy homeostasis, as demonstrated by an increase in food intake and in body weight 
gain after ovariectomy in rats. In the present study, female Wistar rats (200-230 g, N = 5-15 per group), with free access to 
chow, were individually housed in metabolic cages. We investigated food intake, body weight, plasma leptin levels, measured by 
specific radioimmunoassay, and the hypothalamic mRNA expression of orexigenic and anorexigenic neuropeptides, determined 
by real-time PCR, in ovariectomized rats with (OVX+E) and without (OVX) estradiol cypionate treatment (10 µg/kg body weight, 
sc, for 8 days). Hormonal and mRNA expression were determined at pre-feeding and 4 h after food intake. OVX+E rats showed 
lower food intake, less body weight gain and lower plasma leptin levels. In the OVX+E group, we also observed a reduction 
of neuropeptide Y (NPY), agouti-related protein (AgRP) and cocaine- and amphetamine-regulated transcript (CART) mRNA 
expression in the arcuate nucleus and a decrease in orexin A in the lateral hypothalamic area (LHA). There was an increase in 
leptin receptor (LepRb), melanocortin-4 receptor (MC4-R), CART, and mainly corticotropin-releasing hormone (CRH) mRNA in 
the paraventricular nucleus and LepRb and CART mRNA in the LHA. These data show that hypophagia induced by estradiol 
treatment is associated with reduced hypothalamic expression of orexigenic peptides such as NPY, AgRP and orexin A, and 
increased expression of the anorexigenic mediators MC4-R, LepRb and CRH. In conclusion, estradiol decreases food intake, 
and this effect seems to be mediated by peripheral factors such as leptin and the differential mRNA expression of neuropeptides 
in the hypothalamus.
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Gonadal hormones influence food intake and body 
weight in many mammalian species, including mice, rats, 
and women (1,2). In female rats, ovariectomy increases 
food intake and body weight, and these changes can 
be reversed by treatment with estrogen alone (2,3). Ad-
ditionally, the energy balance of female rats oscillates as 
a function of the estrous cycle (3). In humans, abdominal 
fat increases in postmenopausal women, and estrogen 
replacement therapy prevents increases in body weight 
and fat accumulation (4).
The hypothalamus and peripheral signals of the energy 
store play an important role in the control of energy homeo-
stasis. Several neuropeptides expressed in the hypothala-
mus possess orexigenic or anorexigenic effects and also 
affect energy expenditure (5). The paraventricular (PVN) and 
arcuate (ARC) nuclei and lateral hypothalamic area (LHA) 
are hypothalamic regions involved in the neuronal circuitry 
that controls food intake. Neurons in these regions are re-
sponsive to leptin, a hormone whose actions are mediated 
by the long form of the leptin receptor (LepRb) (5).
The ARC contains two distinct neuronal populations that 
express the cocaine- and amphetamine-regulated transcript 
(CART) and proopiomelanocortin (POMC), and activation 
of these neurons is associated with a reduction in food 
intake (5). The cleavage of POMC in the ARC derives the 
α-melanocyte-stimulating hormone (α-MSH), which inhibits 
food intake through hypothalamic melanocortin-3 (MC3-R) 
and melanocortin-4 (MC4-R) receptors. The other neuronal 
population co-expresses orexigenic peptides, neuropeptide 
Y (NPY) and agouti-related protein (AgRP) (5). Both neu-
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ronal populations project to second-order neurons located 
in the PVN, LHA and perifornical area. In the PVN, there is 
high expression of corticotropin-releasing hormone (CRH) 
(5), known to affect the energy balance through its effects 
on food intake and energy expenditure (6). The LHA con-
tains neurons expressing melanin-concentrating hormone 
(MCH) (7) and orexin A (8), two neuropeptides with potent 
effects on feeding, as demonstrated by the increase in food 
intake after intracerebroventricular (icv) administration of 
these peptides (9,10).
Neurons of the PVN and LHA also express MC4-R, 
which has a significant role in the regulation of appetite. 
The icv injection of an MC4-R-specific antagonist increases 
food intake (11), and targeted deletion of the MC4-R in 
mice leads to hyperphagia, maturity onset obesity and 
hyperinsulinemia (12).
Leptin, the product of the lep gene (13), is mainly pro-
duced and secreted by white adipocytes in proportion to 
fat mass, signaling the repletion of body energy stores to 
the hypothalamus (5). In the ARC, leptin inhibits NPY/AgRP 
neurons and activates POMC/CART neurons (5). In fact, 
exogenous administration of leptin results in body weight 
loss, reduced adiposity, and appetite suppression (14). 
Although the effect of estradiol on feeding behavior and 
body weight is well established, the mechanisms underlying 
these effects of estradiol on the central nervous system 
are unknown. To evaluate whether estradiol modulates 
responses to orexigenic or anorexigenic signals in the 
hypothalamus, the present study determined food intake, 
body weight changes and the hypothalamic expression of 
mediators involved in the control of energy homeostasis 
before and after food intake in ovariectomized rats with 
and without estradiol treatment.
Material and Methods
Animals
Female Wistar rats (200-230 g) were housed individually 
in metabolic cages and maintained in a room with constant 
temperature (23 ± 2°C) and under a 12/12-h light/dark cycle 
(dark onset: 18:00 h). Rats were given free access to rat 
chow and tap water. The estrous cycle was assessed with 
daily vaginal smears, and only those animals having three 
consecutive estrous cycles were included in this study.
All procedures performed were approved by Ethics 
Committee for Animal Use of the School of Medicine of 
Ribeirão Preto (Protocol #004/2006). 
Effect of estradiol on food intake, body weight gain, 
plasma leptin levels, and hypothalamic mRNA 
expression
After three consecutive estrous cycles, the animals were 
subjected to bilateral ovariectomy under anesthesia with 
2.5% 2.2.2-tribromoethanol (1 mL/100 g body weight, ip; 
Aldrich, USA). On the next day, rats were treated with es-
tradiol cypionate (OVX+E, 10 µg/kg body weight, sc; Pfizer, 
Brazil) or vehicle (corn oil: 0.1 mL/rat, sc, OVX) between 
9:00 and 10:00 h for 8 days. Food intake and body weight 
were determined daily during this period. On the 8th day, 
food was removed from the metabolic cage at 16:00 h and 
was returned to the cage at dark onset (18:00 h). One set 
of OVX and OVX+E rats was decapitated at 17:00 h (pre-
feeding) and another subgroup of rats (OVX and OVX+E) 
was decapitated at 22:00 h (4 h after feeding). Trunk blood 
and brain tissues from these animals were collected under 
RNase-free conditions for the determination of plasma leptin 
levels and mRNA expression, respectively.
Measurement of plasma leptin levels
Plasma leptin concentration was measured by radioim-
munoassay using the commercial kit Murine Leptin (Linco 
Research, USA) according to the manufacturer protocol. 
The assay sensitivity and intra-assay coefficient of variation 
were 0.5 ng/mL and 1.6%, respectively.
Microdissection
Coronal sections of 600 (PVN) and 1500 µm (ARC and 
LHA) thickness were cut from frozen brain in a cryostat. 
Punches were then immediately obtained based on the 
rat brain atlas coordinates of Paxinos and Watson (15). 
With a stainless steel punch needle 1.5 mm in diameter, 
bilateral PVN punches were taken from sections between 
-1.7 and -2.4 mm relative to the bregma, and bilateral ARC 
and LHA punches were taken from sections between -2.4 
and 3.8 mm relative to the bregma. Punches containing 
the selected hypothalamic regions were stored at 4°C in 
RNAlater reagent (Ambion, USA) for a maximum of 48 h 
until RNA isolation. All procedures were performed under 
standard RNase-free conditions to avoid exogenous RNase 
contamination. 
RNA isolation and cDNA synthesis
Total RNA was extracted using Trizol reagent (Invitrogen, 
USA) according to manufacturer instructions. Total RNA 
was quantified by spectrophotometric absorption at 260 nm 
(Eppendorf Biophotometer, USA). The quality and integrity 
of the isolated RNA were demonstrated using agarose gel 
(1.2%) stained with ethidium bromide. cDNA was synthe-
sized from 250 ηg of total RNA using a high-capacity cDNA 
reverse transcription kit (Applied Biosystems, USA).
Quantitative real-time PCR 
Quantitative real-time PCR was performed using Applied 
Biosystems 7500 real-time PCR system under the following 
conditions: initial denaturation at 95°C for 10 min during the 
first stage and a denaturation (95°C for 15 s) and anneal-
ing/extension (60°C for 1 min) steps for 40 amplification 
cycles in the second stage. The following Taqman® Gene 
Expression Assays (Applied Biosystems, USA) were used 
in this study: Rn 01431703_g1 (AgRP), Rn 00567382_m1 
Figure 1. Mean daily food intake (Panel A), total body weight 
gain (Panel B) after 8 days of treatment with oil (OVX, N = 13) or 
estradiol (OVX+E, N = 15) in ovariectomized rats. Plasma leptin 
levels (Panel C) in the pre-feeding (17:00 h) and post-feeding 
(22:00 h) periods of OVX (N = 7-8) and OVX+E (N = 7-8) groups. 
Data are reported as means ± SEM. *P < 0.05 (unpaired t-test 
or two-way ANOVA followed by the Student-Newman-Keuls post 
hoc test). 
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(CART), Rn 01462137 (CRH), Rn 01491866_s1 (MC4-R), 
Rn 01410145_m1 (NPY), Rn 00561465_m1 (LepRb), Rn 
00565995_m1 (orexin A), Rn 00595020_m1 (POMC), Rn 
00561766_g1 (pro-MCH). Each PCR assay was performed 
in triplicate. Water instead of cDNA was used as a negative 
control. β-actin, glyceraldehyde-3-phosphate dehydroge-
nase and 18S rRNA were used as housekeeping genes 
to normalize the reactions. The relative quantitation was 
determined by the ∆∆CT method. For each sample, the 
threshold cycle (Ct: the cycle at which emission intensity 
rises above baseline values) was determined and nor-
malized to the average of housekeeping genes (∆CT = 
Ctunknown - Cthousekeeping genes). The fold change of mRNA 
in the unknown sample (OVX+E at 17:00 or 22:00 h) rela-
tive to the respective control group (OVX at 17:00 or 22:00 
h) was determined by 2-∆∆CT, where ∆∆CT = ∆CTunknown 
- ∆CTcontrol group). Data are reported as relative mRNA 
expression to that of the control group.
Data analysis
Data are reported as means ± SEM. Statistical analysis 
was performed using the SigmaStat 3.1 software. Data 
concerning 24-h food intake, body weight gain and mRNA 
expression were analyzed by the unpaired t-test. Plasma 
leptin levels were analyzed by two-way analysis of variance 
(ANOVA) followed by the Student-Newman-Keuls post hoc 
test. Differences between means were considered to be 
significant when P < 0.05.
Results
Food intake, body weight and plasma leptin levels
Estradiol treatment (N = 15) induced lower food intake 
(P < 0.01; Figure 1) and body weight gain compared to the 
untreated OVX group (N = 13; P < 0.01).
The OVX+E group showed higher plasma leptin levels 
compared to the OVX group at 17:00 h (pre-feeding: 2.4 ± 
0.3 vs 1.6 ± 0.3 ηg/mL) and at 22:00 h (post-feeding: 3.7 
± 0.3 vs 2.5 ± 0.3 ηg/mL; Figure 1). Plasma leptin levels 
were higher (P < 0.05) at 22:00 h than at 17:00 h in both 
OVX and OVX+E groups. 
Hypothalamic mRNA expression
Figure 2 shows a significant reduction (P < 0.05) in 
NPY and AgRP mRNA expression in the ARC at 17:00 h 
in estradiol-treated animals. In addition, estradiol treatment 
decreased CART mRNA expression in this nucleus both at 
17:00 and 22:00 h. There was no difference in POMC or 
LepRb mRNA expression in the ARC at 17:00 and 22:00 h 
in either the OVX or OVX+E group. 
LepRb, MC4-R, CRH, and CART mRNA expression in 
the PVN is shown in Figure 3. At 17:00 h, LepRb, MC4-R, 
CART, and mainly CRH mRNA expression levels were 
significantly higher in the OVX+E group compared to the 
OVX group. However, no significant difference in mRNA 
Figure 2. Relative NPY, AgRP, CART, LepRb, and POMC mRNA expression in the arcuate nucleus at 17:00 h (pre-feeding) and 22:00 
h (post-feeding) of ovariectomized rats with (OVX+E) and without estradiol treatment (OVX), N = 4-7 per group. Values are reported as 
means ± SEM. LepRb = leptin receptor (Panel A); NPY = neuropeptide Y (Panel B); AgRP = agouti-related protein (Panel C); CART = 
cocaine- and amphetamine-regulated transcript (Panel D); POMC = proopiomelanocortin (Panel E). *P < 0.05 (unpaired t-test). 
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levels of these neuropeptides between the OVX and OVX+E 
groups was found at 22:00 h. Figure 4 shows LepRb, MC4-
R, orexin A, pro-MCH, and CART mRNA expression in the 
LHA of OVX and OVX+E groups. There was no difference 
in the MC4-R and pro-MCH mRNA expression between the 
OVX and OVX+E groups, either at 17:00 or 22:00 h. It was 
also observed that LepRb and CART mRNA expression at 
22:00 h were higher in the OVX+E group compared to the 
OVX group, with no difference at 17:00 h. Orexin A mRNA 
expression was lower at 17:00 h in the OVX+E rats, with 
no difference between groups at 22:00 h. 
Discussion 
The present study demonstrated that estradiol treatment 
of OVX rats induced lower food intake, less body weight 
gain and lower plasma leptin levels both before and after 
feeding. Furthermore, the mRNA expression of several 
Figure 3. Relative LepRb, MC4-R, CART, and CRH mRNA expression in the paraventricular nucleus at 17:00 h (pre-feeding) and 22:00 
h (post-feeding) of ovariectomized rats with (OVX+E) and without estradiol treatment (OVX), N = 4-8 per group. Data are reported as 
means ± SEM. LepRb = leptin receptor (Panel A); MC4-R = melanocortin-4 receptor (Panel B); CART = cocaine- and amphetamine-
regulated transcript (Panel C); CRH = corticotropin-releasing hormone (Panel D). *P < 0.05 (unpaired t-test).
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neuropetides in specific hypothalamic nuclei showed that 
estradiol can modify the mRNA expression of neuropeptides 
and receptors localized in the ARC, PVN and LHA.
The lower food intake and reduced body weight gain of 
the OVX+E group is in agreement with the well-established 
role of estradiol in modulating energy homeostasis. Indeed, 
variation of food intake and body weight of adult female rats 
can be correlated with the estrous cycle, with lower food 
intake during the peri-ovulatory phase (2).
We observed increased plasma leptin levels at 17:00 
and 22:00 h in estradiol-treated animals. These data agree 
with a previous report (16), but differ from data presented in 
another study, which reports that estradiol treatment does 
not modify plasma leptin levels (17). The reason for this 
discrepancy may be related to the experimental protocols, 
duration of estradiol treatment and feeding status. To re-
inforce the notion that estrogens affect leptin secretion, it 
has been shown that estradiol has a direct effect on white 
adipocytes, increasing the synthesis and secretion of leptin 
(16), as well as its mRNA expression (18). The presence of 
estrogen receptors in adipocytes (19) provides a possible 
mechanism by which estrogen may modulate food intake, 
increasing leptin release. 
We also observed increased plasma leptin levels in the 
post-feeding period (22:00 h), when compared to the pre-
feeding period (17:00 h) in both groups (OVX and OVX+E). 
Leptin secretion is related to adiposity; however, leptin 
gene expression in white adipose tissue and circulating 
leptin are also regulated by acute or short-term stimulation 
(20,21). These data suggest that food intake may modulate 
leptin secretion and reinforce the notion that it may play a 
role in the process of satiety, modulating meal size (22). 
The increase in plasma leptin levels after feeding may be 
mediated, in part, by insulin, which directly stimulates the 
synthesis and secretion of leptin by adipocytes (23). 
It has been demonstrated that estrogen-deficient rats 
show insensitivity to central leptin administration, which may 
contribute to their increased body weight (24). We observed 
an increase of LepRb mRNA expression in the PVN in the 
pre-feeding period (17:00 h) and in the LHA in the post-
feeding period (22:00 h) in the OVX+E group. Using the 
whole hypothalamus, Rocha et al. (17) demonstrated an 
increase in LepRb mRNA expression in intact rats treated 
with estradiol. The abundance of leptin receptors is likely 
NPY and AgRP mRNA expression in the ARC that could 
be due to higher plasma leptin levels in the OVX+E group. 
This result is consistent with a report from Pelletier et al. 
(26), which showed that estradiol administration to OVX 
female mice reduced NPY mRNA expression in the ARC. 
The present results reinforce the idea that the interaction 
Figure 4. Relative LepRb, MC4-R, orexin A, pro-MCH, and CART mRNA expression in the lateral hypothalamic area at 17:00 h (pre-
feeding) and 22:00 h (post-feeding) of ovariectomized rats with (OVX+E) and without estradiol treatment (OVX), N = 5-8 per group. 
Data are reported as means ± SEM. LepRb = leptin receptor (Panel A); MC4-R = melanocortin-4 receptor (Panel B); orexin A (Panel 
C); pro-MCH = pro-melanin-concentrating hormone (Panel D); CART = cocaine- and amphetamine-regulated transcript (Panel E). *P 
< 0.05 (unpaired t-test).
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to be an important determinant of leptin sensitivity (25). 
Therefore, though no change of LepRb mRNA expression 
was observed in the ARC in the present study, increased 
expression of this receptor in the PVN and LHA might con-
tribute to the lower food intake by OVX+E rats. 
Our data showed that estradiol treatment reduced 
of leptin and estrogen signaling in hypothalamic regions is 
related to energy homeostasis (27,28). It is also important 
to point out that estradiol may also interact with the action 
of ghrelin on NPY neurons by attenuating the orexigenic 
effects of this peptide produced by the stomach (2).
In the ARC, we found a decrease of CART expression in 
OVX+E rats. CART neurons in the ARC have been shown 
to project to areas containing neurons that show immu-
noreactivity to gonadotropin-releasing hormone (GnRH) 
(29). Therefore, CART neurons from the ARC, under the 
influence of estradiol, might be involved in the control of 
the hypothalamic-pituitary-ovarian axis. 
It is interesting to note that, in spite of the co-localization 
of CART and POMC in the ARC, CART was reduced in 
OVX+E rats, but there was no change in POMC mRNA 
expression in these rats. This result agrees with previous 
reports using different experimental models (30,31) that 
also showed a differential expression of CART and POMC 
mRNAs, suggesting a distinct intracellular regulation of 
these neuropeptides.
We observed a marked increase of CRH mRNA in the 
PVN of OVX+E rats during the pre-feeding period. CRH 
has also been shown to mediate the anorexigenic effects of 
leptin (32). Besides having anorexigenic effects, CRH has 
been shown to increase sympathetic nerve activity in brown 
adipose tissue involved in the control of thermogenesis 
(6) and also to mediate leptin actions on the expression of 
uncoupling protein mRNA in this tissue (33). Parvocellular 
PVN neurons sensitive to estrogen have been shown to 
possess reciprocal projections with neurons in the nucleus 
of the solitary tract, which participate in the PVN-hindbrain 
pathway involved in the control of energy homeostasis (2). 
Thus, our result suggests that estradiol, by increasing CRH 
mRNA expression in the PVN, may contribute to diminished 
food intake and to enhanced energy expenditure.
We also observed that estradiol increased CART gene 
expression in the PVN during the pre-feeding period. Wang 
et al. (34) showed that the injection of this neuropeptide 
into the PVN decreased NPY-induced feeding and body 
weight. Thus, our data indicate that the increased CART 
in the PVN could mediate the inhibitory effect of estradiol 
on food intake. In addition, estradiol treatment induced an 
increase in MC4-R mRNA expression in the PVN during the 
pre-feeding period. The activation of this receptor decreases 
food intake and also stimulates sympathetic outflow to brown 
adipose tissue and, consequently, thermogenesis (35). A 
decrease in MC4-R expression after food intake was also 
observed in the group treated with estradiol. This result 
is consistent with previous studies that demonstrated a 
down-regulation of this receptor after feeding (36,37). On 
the basis of the present study, we suggest that increased 
downstream MC4-R signaling may also contribute to the 
inhibition of food intake and the enhancement of energy 
expenditure induced by estradiol.
The hypophagic effect of estradiol was also associated 
with a reduction of orexin A mRNA expression in the LHA 
at 17:00 h, indicating that change in this neuropeptide 
expression also contributes to the decrease in food intake 
observed in OVX+E rats. There is substantial evidence 
demonstrating that orexin has other physiological effects, 
being involved in the control of sexual behavior and GnRH 
and LH release (38). The significance of the differential 
expression of orexin mRNA found in the present study and 
its participation in the hypothalamic-pituitary-ovarian axis 
remains to be established. We observed that in the LHA 
there was no difference in MCH mRNA expression, but 
there was higher CART expression at 22:00 h in the OVX+ 
E group. It was shown that CART colocalizes extensively 
with MCH in the LHA (39). Though the functions of CART 
in this area are not well established, it could counteract the 
orexigenic effect of MCH (39).
The results of the present study provide evidence that 
estradiol affects energy homeostasis through its effects on 
food intake, which are mediated by peripheral factors, such 
as leptin released by white adipose tissue and by differential 
expression of hypothalamic neuropeptides.
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